/PRNewswire/ – BioAmber Inc., a leader in renewable materials, today announced that George F.J. Gosbee is joining its board of directors, effective today. Mr. Gosbee will replace Henry “Pete” Linsert, Jr. who resigned his board seat for personal reasons, effective today.
George Gosbee brings extensive capital markets experience and deep knowledge of the oil and gas industry. His profile is complementary to existing board members and he will provide insight and advice on navigating capital markets, positioning the company vs. fossil fuels, approaching new investors and raising the Company’s visibility. Mr. Gosbee has been elected a Class II director, to hold office until the 2018 annual meeting of stockholders. Mr. Gosbee will serve on the Nominating and Corporate Governance Committee and the Compensation Committee.
“On behalf of the entire board and management team, I would like to thank Pete for his valuable insight and contributions over the past 20 months,” said Ray Land, Chairman of the board. “Pete’s experience and wisdom will be missed, but we are thrilled to have someone of George’s caliber and financial background joining the board.”
About George F.J. Gosbee
Mr. Gosbee’s career spans over 20 years in corporate finance, investment banking, global capital markets and advisory. Prior to founding AltaCorp Capital in 2010, Mr. Gosbee was Chairman, President and CEO of Tristone Capital Global Inc., a global energy investment firm which he founded. Tristone became the largest global independent energy advisory firm and was acquired by an international bank in 2009. His current firm, AltaCorp Capital, is an advisory firm that is partnered with Alberta Treasury Branch (ATB Financial), a wholly owned subsidiary of the Government of Alberta.
Mr. Gosbee is a former Governor of the National Hockey League (NHL). He led a group to purchase the Arizona Coyotes and restructure the Club. Currently he is an Alternate Governor on the NHL Board of Governors and Co-owner of the Arizona Coyotes.
Mr. Gosbee was the Vice Chairman of Alberta Investment Management Co (AIMCo) and was called on to assist in the creation of the crown corporation. He spent 8 years as the Vice Chair of AIMCo, which is a $90 billion institutional investment fund, and currently is a Director. Mr. Gosbee is a former Director of the TMX Group and a former Board Member of Chrysler Group LLC in Detroit, where he served on behalf of both the Canadian Federal and Provincial (Ontario) governments to oversee their collective investment in the company and assist in the restructuring.
Source: BioAmber
The Food and Drug Administration’s top scientist Namandjé Bumpus will assume the role of principal deputy commissioner when longtime agency leader Janet Woodcock retires from that role in early 2024, according to an announcement Thursday.
US biopharma AbbVie has agreed to acquire ImmunoGen in a deal which values the company at about $10.1 billion and gives AbbVie access to flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved for platinum-resistant ovarian cancer (PROC), as well as a pipeline of promising next-generation ADCs.
EUROAPI today announced the appointment of David Seignolle as Chief Operating Officer, succeeding Eric Berger, and Marion Santin as Chief Legal, Compliance, and IP Officer, both joining the company’s Executive Committee. In his new role, David Seignolle will lead the transformation of the Industrial Operations organization.
